CAS: 1454585-06-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine REF: AN-AG00ABTACAS: 1454585-06-8 | ≥98%(HPLC) | 122,00 €~210,00 € | Jue 02 May 24 |
 | SR-3029 REF: TM-T3972CAS: 1454585-06-8 | 100% | 46,00 €~671,00 € | Jue 09 May 24 |
 | SR 3029 REF: 3D-EIC58506CAS: 1454585-06-8 | Min. 95% | A consultar | Jue 13 Jun 24 |
![N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine](https://static.cymitquimica.com/products/AN/thumb/AG00ABTA.jpg)
N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine
CAS:1454585-06-8
Fórmula:
C23H19F3N8O
Pureza:
≥98%(HPLC)
Forma y color:
Solid
Peso molecular:
480.4452
Ref: AN-AG00ABTA
| 5mg | 122,00 € | |
| 25mg | 161,00 € | |
| 50mg | 174,00 € | |
| 100mg | 210,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Mayo de 2024
SR-3029
CAS:1454585-06-8
SR-3029 is a potent and highly specific CK1δ/CK1ε inhibitor.
Fórmula:
C23H19F3N8O
Pureza:
100%
Forma y color:
Solid
Peso molecular:
480.45
Ref: TM-T3972
| 1mg | 46,00 € | |
| 2mg | 59,00 € | |
| 5mg | 94,00 € | |
| 10mg | 150,00 € | |
| 25mg | 291,00 € | |
| 50mg | 461,00 € | |
| 100mg | 671,00 € | |
| 1ml*10 (DMSO) | 94,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
SR 3029
CAS:1454585-06-8
SR 3029 is a small-molecule drug that has potent antitumor activity. It inhibits cancer cell …
Fórmula:
C23H19F3N8O
Pureza:
Min. 95%
Peso molecular:
480.45 g/mol
Ref: 3D-EIC58506
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 13 de Junio de 2024
